Insights from 2023 ESGO Annual Meeting

 

Insights from 2023 ESGO Annual Meeting
J

ESGO 2023 Insights: "Long-Term Follow Up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer"

By Insights from 2023 ESGO Annual Meeting FEATURING Jose Perez-Fidalgo
By Insights from 2023 ESGO Annual Meeting FEATURING Jose Perez-Fidalgo
0 views
November 24, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin

Featured Video

19:30
AstraZeneca Oncology

The Importance of HRD Testing in Advanced Ovarian Cancer

Feat. M. Markman
Videos
16:44
Insights from 2023 ESGO Annual Meeting

Is There a Role for Predictive Biomarker in Gynecological Malignancy…

Feat. V. Heinzelmann-Schwarz
10:02
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Long-Term Follow Up of Selinexor Maintenan…

Feat. J. Perez-Fidalgo
16:40
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Latest Clinical Trial Updates That Have Ch…

Feat. C. Marth
14:24
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Clinical Errors in the Management of Papil…

Feat. V. Sklyarova
14:05
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comp…

Feat. A. Clamp
18:13
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "CA125 Kinetics - KELIM to Help Select Ovar…

Feat. B. You
10:43
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Are We Changing the History of Endometrial…

Feat. M. Raza Mirza
08:19
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Final OS and Long-Term Safety in the ENGOT…

Feat. M. Raza Mirza